神经外科手术与非手术治疗随机对照试验的系统综述
该系统综述检索2000至2017年PubMed、Embase及四个试验注册库,评估82项比较手术与非手术治疗的神经外科随机对照试验的设计质量与结局。结果显示36.4%的试验未报告组间差异,3.7%倾向非手术治疗,高Jadad评分(≥4)与展示手术获益呈负相关(P<0.05)。
要点
- 82项随机对照试验中脊柱40项、神经血管与神经创伤19项、功能神经外科11项。
- 36.4%的试验未报告手术与非手术治疗差异,3.7%倾向非手术治疗。
- 高Jadad评分(≥4)与展示手术获益呈负相关(P<0.05)。
核心结论
- 比较手术与非手术治疗的神经外科随机对照试验常发现手术获益,但结局测量与预计入组数的变更常见且资金来源未总是报告。
研究设计与样本
- 系统综述,检索2000至2017年PubMed、Embase数据库及四个试验注册库,纳入82项比较手术与非手术治疗的神经外科随机对照试验,评估研究设计、资金、结局指标调整、患者入组及学术影响。
主要发现
- 82项试验中脊柱40项、神经血管与神经创伤19项、功能神经外科11项、周围神经10项、垂体手术2项。
- 84项随机对照试验已注册,其中部分正在进行,注册率因亚专科而异。
- 资金主要来自非工业机构(58.5%),但25.6%的试验未报告资金来源。
- 36.4%的试验未报告手术与非手术治疗差异,3.7%倾向非手术治疗。
- 主要和次要结局指标分别在13.2%和34.2%的试验中被更改,且因亚专科而异;41.9%的试验较预计入组减少≥10%,12.9%增加≥10%;7.3%的注册试验终止,多因招募过慢。
关键数值与推荐
- 亚专科、注册、资金、盲法、人群规模及结局指标更改与报告手术获益无显著关联。
- 高Jadad评分(≥4)与展示手术获益呈负相关(P<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A randomized controlled trial (RCT) remains the pinnacle of clinical research design. However, RCTs in neurosurgery, especially those comparing surgery to non-operative treatment, are rare and their relevance and applicability have been questioned. This study set out to assess trial design and quality and identify their influence on outcomes in recent neurosurgical trials that compare surgery to non-operative treatment. METHODS: From 2000 to 2017, PubMed and Embase databases and four trial registries were searched. RCTs were evaluated for study design, funding, adjustments to reported outcome measures, accrual of patients, and academic impact. RESULTS: Eighty-two neurosurgical RCTs were identified, 40 in spine disorders, 19 neurovascular and neurotrauma, 11 functional neurosurgery, ten peripheral nerve, and two pituitary surgery. Eighty-four RCTs were registered, of which some are ongoing. Trial registration rate differed per subspecialty. Funding was mostly from non-industry institutions (58.5%), but 25.6% of RCTs did not report funding sources. 36.4% of RCTs did not report a difference between surgical and non-operative treatment, 3.7% favored non-operative management. Primary and secondary outcome measures were changed in 13.2% and 34.2% of RCTs respectively and varied by subspecialty. 41.9% of RCTs subtracted ≥ 10% of the anticipated accrual and 12.9% of RCTs added ≥ 10%. 7.3% of registered RCTs were terminated, mostly due to too slow recruitment. Subspecialty, registration, funding, masking, population size, and changing outcome measures were not significantly associated with a reported benefit of surgery. High Jadad scores (≥ 4) were negatively associated with a demonstration of surgical benefit (P < 0.05). CONCLUSIONS: Neurosurgical RCTs comparing surgical to non-operative treatment often find a benefit for surgical treatment. Changes to outcome measurements and anticipated accrual are common and funding sources are not always reported.
引用
- Martin E, Muskens IS, Senders JT, et al. Randomized controlled trials comparing surgery to non-operative management in neurosurgery: a systematic review. Acta Neurochir (Wien). 2019. PMID: 30798479. doi:10.1007/s00701-019-03849-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。